Fenofibrate improves renal function by amelioration of NOX‐4, IL‐18, and p53 expression in an experimental model of diabetic nephropathy
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cellular Biochemistry"
DOI: 10.1002/jcb.27055
Abstract: Among several pathological mechanisms involved in diabetic nephropathy, oxidative stress, inflammation, and apoptosis play a prominent role. Fenofibrate, a peroxisome proliferator‐activated receptor‐α (PPAR‐α) agonist, has markedly improved oxidative stress and inflammatory responses, but there is… read more here.
Keywords: expression; diabetic nephropathy; fenofibrate; renal function ... See more keywords